semaglutide help inflammation decrease in Cardiometabolic Diseases: SELECTing the Target Population Effect of once-weekly subcutaneous semaglutide – The weight-loss-independent hepatoprotective benefits of

Consulting with Your Doctor Before Pausing For your safety and well-being, its important to discuss any plans to pause your GLP-1 medications with your doctor before doing so

Weekly rate applies while enrolled

0.8% decrease

Research in aging mouse models shows that MOTS-c administration suppresses SASP markers and reduces the burden of senescent cells in metabolically active tissues [2]

It's important to note that semaglutide carries a boxed warning about the risk of thyroid C-cell tumors and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2

Monitor closely Track your body weight, changes in blood sugar levels, appetite changes, and side effects carefully, and consult with your doctors if you have any questions